BRIEF-Kite Pharma names Richard Wang CEO of Fosun Kite Biotechnology Co Ltd

March 5 (Reuters) - Kite Pharma Inc :

* Richard L. Wang named chief executive officer of Fosun

Kite Biotechnology Co, Ltd, a joint venture to lead development

of axicabtagene ciloleucel and other engineered T-cell therapies

for treatment of cancers in China

* Richard wang named CEO of Fosun Kite Biotechnology Co Ltd

Source text for Eikon:

Further company coverage: